Gastrin stimulates transcription of the human histidine decarboxylase (HDC) gene through binding to the G-protein-coupled cholecystokinin-B/gastrin receptor. We have explored the possibility that mitogen-activated protein kinase cascades play a role in mediating the effects of gastrin on transcription in a gastric cancer (AGS-B) cell line. Gastrin and phorbol 12-myristate 13-acetate (PMA) treatment of AGS-B cells was found to increase the phosphorylation of tyrosine residues of extracellular signal-regulated kinases (ERKs) 1 and 2 and increase ERK activity as determined by the in vitro phosphorylation of myelin basic protein. Reporter gene assays also demonstrated that gastrin and PMA stimulated Elk-1-and c-Myc-dependent transactivation, consistent with gastrin-and PMA-induced activation of ERKs. Overexpression of wild type ERK-1 and ERK-2 or activation of endogenous ERKs using activated MEK-1 (mitogen-activated protein kinase kinase or ERK kinase) overexpression stimulated HDC promoter activity in a dose-dependent fashion. Interruption of the ERKrelated pathway using expression vectors for kinasedeficient ERKs or an ERK-specific phosphatase (PAC-1) blocked gastrin-and PMA-stimulated HDC promoter activity. In contrast, inhibition of the Jun kinase pathway using an interfering dominant negative SEK-1 (stressactivated protein kinase/ERK-1) mutant did not inhibit HDC promoter activity. Furthermore, whereas gastrin stimulated phosphorylation of Shc proteins and association with Grb2, activation of the HDC promoter was not influenced by expression of dominant negative Ras (N15 or N17) proteins. However, gastrin stimulated Raf-1 kinase activity, and activation of the HDC promoter was blocked by coexpression of a dominant negative Raf-1 construct. Overall, these data demonstrate that gastrin regulates HDC transcription in a Rafdependent, Ras-independent fashion predominantly through activation of the ERK-related pathway.
The CCK 1 -B/gastrin receptor, a member of the family of G-protein-coupled receptors that contain seven membranespanning regions, has a high affinity for both gastrin and cholecystokinin octapeptide (CCK-8) (1) (2) (3) . Agonist binding to this receptor has been shown to activate a phospholipase C that hydrolyzes phosphatidylinositol bisphosphate, generating inositol 1,4,5-trisphosphate and diacylglycerol, which mobilizes intracellular Ca 2ϩ and activates protein kinase C, respectively (4, 5) . Whereas CCK-B/gastrin receptors have been detected in both the brain and the pancreas of most mammalian species, the major target of gastrin in the gastrointestinal tract is the enterochromaffin-like cell of the gastric corpus. Gastrin stimulation of enterochromaffin-like cells leads to increased histamine secretion and elevated activity of histidine decarboxylase (HDC). HDC catalyzes the decarboxylation of L-histidine and thus is the rate-limiting enzyme in the stomach for the generation of histamine, the major gastric acid secretogogue. Studies from a number of groups have now shown that gastrin-stimulated HDC enzymatic activity is paralleled by increased HDC gene expression in the gastric corpus and isolated enterochromaffin-like cells (6 -9) . In addition, targeted disruption of the CCK-B/gastrin receptor in mice leads to decreased expression of the HDC gene in the gastric corpus (10, 11) .
To study transcriptional regulation of HDC by gastrin, we developed the AGS-B cell line, a human gastric cancer cell line stably expressing the recombinant human CCK-B/gastrin receptor (6) . Experiments from our laboratory have shown that the HDC promoter is regulated transcriptionally by gastrin preferentially through a protein kinase C-dependent signaling pathway (6) . In addition, recent studies from our laboratory have provided evidence that transcriptional stimulation of the HDC gene by gastrin or phorbol 12-myristate 13-acetate (PMA) is mediated by a 23-nucleotide cis-acting element, the gastrin response element (GAS-RE), which is located downstream of the transcriptional start site (12) . Gastrin and PMA treatment of AGS-B cells induces enhanced binding of a nuclear factor to the GAS-RE. In a subsequent study, we found activation of AP-1 to be essential for gastrin-stimulated HDC transcription, although the mechanism is likely indirect (13) .
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¶ Supported by a National Institutes of Health training grant. ʈ Supported by National Institutes of Health Grants DK48077 and CA67463. To whom correspondence should be addressed. Tel.: 617-726-922; Fax: -617-726-3673; E-mail: Wang@Helix.MGH.Harvard.Edu. tion of specific transcriptional effects by the CCK-B/gastrin receptor have not been defined fully. Although the CCK-B/ gastrin receptor has been linked to phospholipase C and activation of protein kinase C (4, 5) , the steps downstream of protein kinase C activation are not entirely clear. Because the mitogen-activated kinase (MAPK) pathway has been characterized as an important signaling route for the transmission of protein kinase C effects on the activity of the AP-1 complex (14) , MAPK-regulated signaling could represent an important pathway for mediating the transcriptional effects of gastrin. The best studied members of the MAPK family are the extracellular signal-regulated kinases (ERKs), 42-and 44-kDa serine/threonine kinases encoded by the ERK-2 and ERK-1 genes, respectively (14) . The ERKs are activated enzymatically through tyrosine and threonine phosphorylation by their upstream activator kinases MEK (MAPK kinase or ERK kinase) in response to growth-promoting factors acting on a variety of cell surface receptors (15) . Following activation, the ERKs upregulate the biological activity of a number of downstream targets, including transcription factors such as c-Myc, c-Fos, and p62 TCF, through specific phosphorylation of these factors (14) . The other branch of the MAPK family is represented by the JUN kinases (JNKs), which are activated by tumor necrosis factor ␣ and agents that induce cellular stress but can also be activated through signaling by G-protein-coupled receptors.
These observations led us to investigate a possible role for the MAPK cascades in mediating the effects of gastrin on activation of the HDC promoter. We find that the ERK pathway is essential for transmission of the gastrin effects on the transcriptional activity of the human HDC promoter and that the CCK-B/gastrin receptors expressed in AGS-B gastric cancer cells are linked through a Ras-independent, Raf-dependent mechanism to ERK signaling cascades.
EXPERIMENTAL PROCEDURES
Materials-Dulbecco's modified Eagle's medium, fetal calf serum, penicillin-streptomycin, and EDTA-trypsin were obtained from Bio Whittaker, Walkerville, MA. Sulfated gastrin-17 was purchased from Peninsula Laboratories, San Diego. PMA was obtained from BIOMOL Research Laboratories, Plymouth Meeting, PA. Epidermal growth factor was obtained from Sigma.
Tissue Culture and Transfections-Transient transfections were carried out in AGS-B cells or AGS-B/1.8-kb hHDC-Luc cells, which have been described previously (13) . Briefly, the AGS-B stable cell line was derived from AGS cells (American Type Culture Collection) through stable transfection of the expression construct CCK-B-pcDNA I-Neo, which contains the full-length coding region of the human CCK-B/ gastrin receptor and the neomycin resistance gene (6) . The AGS-B/ 1.8-kb hHDC-Luc stable cell line was derived from the AGS-B cells through transfection of the 1.8-kb hHDC-Luc and CMV-hygromycin constructs, followed by selection in hygromycin. For transient transfections, AGS-B or AGS-B/1.8-kb hHDC-Luc cells were plated at a density of 1 ϫ 10 6 cells/35-mm well and transfected the next day. Transient transfections of cultured cells were carried out using the calcium phosphate precipitation technique (DNA transfection kit, 5 Prime-3 Prime, Inc.) as described previously (6) . Gastrin and PMA were added at maximal stimulatory concentrations (10 Ϫ7 M) 12-24 h after transfection, and cells were harvested and luciferase assays performed at 48 h. Luciferase assays were carried out using luciferin, ATP, coenzyme A (Promega system) with a Monolight Luminometer (Analytical Luminescence Laboratory). CAT assays were performed as described previously (13) . Incubations were performed in triplicate or quadruplicate, and results were calculated as the mean Ϯ S.D. Values for HDC-luciferase activity were expressed as a fold increase in luciferase activity compared with untreated controls. Activities in all transfection experiments represented the mean Ϯ S.D. of at least four to six independent transfections. Activities varied Ͻ15% among transfection experiments.
DNA Constructs and Plasmids-GAL4-c-Jun WT, GAL4-c-Jun MT(AA), 5ϫGAL-Luc, and GAL4-Elk-1 have all been described (16). GAL4-c-Jun WT expresses the GAL4 DNA binding domain linked to amino acids 1-246 of human c-Jun. GAL4-c-Jun MT(AA) has Ser-63 and Ser-73 of c-Jun mutated to alanines. GAL4-Elk-1 contains the GAL4 DNA binding domain linked to the Elk-1 transactivation domain. 5ϫGAL-Luc contains five consensus GAL4 DNA binding sites (17-mer) subcloned into p20-Luc. The GAL4-c-Myc constructs (wild type, mutant) and the GAL4-VP16 construct were a kind gift from Anil K. Rustgi. The GAL4-c-Myc wild type construct contains the GAL4 DNA binding domain fused to amino acids 1-103 of c-Myc. The GAL4-c-Myc mutant construct contains changes of threonine and serine to alanine at amino acids 59 and 62, respectively, but otherwise is identical to the wild type construct. The p[AP1]4 MCAT3, or 4ϫTRE-CAT, contains four copies of the TRE sequence from the SV40 enhancer inserted upstream of a minimal human metallothionein IIA promoter in the CAT reporter plasmid MCAT3 and has been described previously (13) .
The ERK cDNAs and mutants were all subcloned into the expression vector pCMV5 and driven by a cytomegalovirus promoter (16) . Wild type ERK-1 and ERK-2 constructs contained full-length cDNAs, whereas the mutant ERKs (K71R ERK-1 and K52R ERK-2) were kinase-deficient. Previous studies have shown that these mutants possess Ͻ1% and 5% of wild type kinase activity in vitro (17) , and expression of these mutants has been shown to interfere with endogenous ERK activity (16) . The SEK-1 constructs, pEBG-SEK-1 and pEBG-SEK-1KR, have been described previously (18) . pEBG-SEK-1 contains the SEK-1 cDNA cloned into the mammalian expression vector pEBG, which drives the expression of a glutatione S-transferase fusion protein, including the entire coding sequence of SEK-1. pEBG-SEK-1KR (or DN SEK-1) is a kinase-inactive mutant in which the critical lysine (Lys-129) in the ATP binding site has been mutated to arginine and has been shown to act as a dominant inhibitor of JNK activation in vivo (18) . The catalytically active (PMT2T-PAC-1 or PAC-1 WT) and catalytically inactive (PMT2T-PAC-1-S257 or PAC-1 MT) constructs have been reported (19) . The substitution of Cys for Ser at position 257 results in a catalytically inactive form of PAC-1. The wild type MEK and constitutively active mutant MEK (⌬ N3-S18E-S222D) have also been described (20) . The mutations at serine 218 and serine 222 and deletion of residues outside the kinase catalytic core result in a constitutively active MAPK kinase mutant with a strongly elevated basal activity (20) .
The constructs Ha-ras-Asn-17 (RasN17) and Ha-ras-Ala-15 (RasN15) are dominant negative Ras constructs that preferentially bind GDP versus GTP and specifically interfere with the function of endogenous Ras proteins. The constructs contain the mutant ras gene under the control of the murine mammary tumor virus promoter (21, 22) . The dominant negative Raf-1 construct was also a kind gift of G. M. Cooper (23) .
The human 1.8-kb HDC-luciferase constructs and HDC deletion constructs have been described (12) . The GAS-RE/TK-Luc construct, which is derived from TK-Luc (24) but also contains the human HDC GAS-RE sequences ligated upstream of the herpes simplex virus 1 thymidine kinase promoter, has been reported (12) .
Immunoprecipitations and Western Blotting-AGS-B cells were grown to near confluence and then serum starved for 36 h in serum-free Ultraculture (Bio Whittaker) medium. Cells were stimulated with gastrin (5 ϫ 10 Ϫ8 M) or PMA (10 Ϫ7 M) for 5 min at 37°C, rinsed with ice-cold phosphate-buffered saline, and then lysed with 1 ml of lysis buffer (20 mM Tris-HCl, pH 7.8, 150 mM NaCl, 2 mM EDTA, 0.1% Triton X-100, 100 M sodium orthovanadate, 10 mM NaF, and 10 g/ml each aprotinin, leupeptin, and pepstatin, and 2 mM phenylmethylsulfonyl fluoride). The lysates were precleared by incubating them with normal rabbit serum and protein A-Sepharose beads (Pharmacia Biotech Inc.). Cell debris was removed by centrifugation, and 1 g of antiserum to ERK-1 or ERK-2 (Santa Cruz Biochemicals), Shc (Transduction Laboratories), Grb2 (Santa Cruz Biochemicals), or JNK-1 (Santa Cruz Biochemicals) was added to the supernatant standardized for protein content (approximately 1.0 mg of protein). After 1 h of gentle mixing at 4°C, immune complexes were collected on protein A-Sepharose beads and washed three times with ice-cold lysis buffer. SDS-sample buffer was added, and the beads were boiled for 5 min.
For Western blotting, proteins (whole cell lysates or immunoprecipitates) were separated by SDS-polyacrylamide gel electrophoresis on 7.5% polyacrylamide gels and transferred at 10°C for 2 h at 50 volts to polyvinylidene difluoride membranes (Millipore) using transfer buffer consisting of 192 mM glycine, 25 mM Tris. Nonspecific binding was blocked with Tris-buffered saline plus Tween 20 (TBST) (10 mM TrisHCl, pH 7.6, 150 mM NaCl, 0.05% Tween 20) containing bovine serum albumin (1%) for 2 h at room temperature. The membrane was then incubated with anti-phosphotyrosine antibody (4G10; 1 g/ml, Upstate Biotechnology, Inc.) or anti-JNK antibody (1 g/ml) overnight at 4°C. The membrane was washed three times with TBST and then incubated with sheep anti-mouse IgG-horseradish peroxidase conjugate (Amersham) (1:10,000 dilution) in TBST for 1 h at room temperature. After four washes with TBST, bands were visualized with the enhanced chemiluminescence system (ECL, Amersham Corp.).
MAPK Activity Assays-For an immune complex assay of MAPK activity, the protein A-Sepharose beads were resuspended in 100 l of a buffer containing 50 mM HEPES, pH 7.5, 1 mg/ml bovine serum albumin, 10 mM MgCl 2 , 150 mM NaCl, 2 mM sodium vanadate, 0.1% ␤-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride, 5 mM benzamidine, 12.5 g of myelin basic protein (MBP, Sigma), and 100 M [␥-
32 P]ATP (460 mCi/mmol). The reaction mixture was incubated at 30°C for 30 min, with frequent mixing. Phosphorylated proteins were then resolved by denaturing polyacrylamide gel electrophoresis and visualized by autoradiography. The density of the resulting bands was determined using a Molecular Dynamics personal densitometer with Imagequant versiom 3.22 software.
Raf-1 Protein Kinase Assay-For determination of Raf-1 kinase activity in response to gastrin and PMA, AGS-B cells were treated with gastrin or PMA or left untreated, and Raf-1 was immunoprecipitated from total cell lysates with a specific anti-Raf-1 antibody. Immunoprecipitates were collected with protein A-Sepharose beads and incubated with 1.0 g of purified MEK protein (Santa Cruz Biochemicals) in the presence of 10 Ci of [␥-32 P]ATP (25) . Reaction products were separated on an SDS-polyacrylamide gel and autoradiographed. Experimental conditions and buffers were similar to MAPK assays described above.
RESULTS

Overexpression of ERK-1 and ERK-2 or MEK-1 Stimulates HDC Promoter Activity in AGS-B Cells-
To evaluate the responsiveness of the hHDC promoter to overexpression of ERKs, we cotransfected into AGS-B cells the 1.8-kb hHDC-Luc construct along with CMV expression constructs for ERK-1 or ERK-2. The AGS-B gastric cancer cell line stably expresses the human CCK-B/gastrin receptor and has been described previously (6) . Overexpression of ERK-1 stimulated hHDC promoter activity up to 12-fold (Fig. 1) . Similar results were obtained with overexpression of ERK-2 (not shown). Promoter activity showed no additional stimulation when both ERK isoforms were coexpressed simultaneously (Fig. 1) . The transcriptional activity of the pT81-Luc construct, which contains the luciferase gene under the control of an enhancerless thymidine kinase promoter, was not increased significantly by ERK overexpression (not shown).
The effect of activation of endogenous ERKs was then investigated through transfection of wild type (WT) and mutant MEK-1 constructs. MEK-1 has been characterized as a dual specificity protein kinase that acts upstream of the ERKs and activates its targets by tyrosine and threonine phosphorylation (14, 26, 27) . Substitution of Ser-218 and Ser-222 in the catalytic region of MEK by glutamic or aspartic acid or deletion of the NH 2 -terminal ␣-helix (⌬ mutants) resulted in MEK-1 mutants with strongly increased kinase activity toward the ERKs (20) . When modifications in both regions were combined (mutant ⌬-N3-S218E-S222D), kinase activity was increased up to 400-fold when compared with WT MEK-1 (20) . In AGS-B cells, transfection of WT MEK-1 had little effect on hHDC promoter activity, but WT MEK-1-transfected cells remained quite responsive to gastrin (Fig. 2) . In contrast, transfection of the mutant MEK-⌬-N3-S218E-S222D substantially increased hHDC promoter activity, but gastrin stimulation resulted in no further increase (Fig. 2) .
Gastrin and PMA Stimulate c-Myc-and Elk-1-dependent Transactivation-Further evidence for a role for ERKs in the regulation of HDC transcription was provided by transfection experiments with GAL4-c-Myc and GAL4-Elk-1 fusion genes, along with a GAL4-luciferase reporter construct. We used a fusion containing the DNA binding domain of the yeast transcription factor GAL4 linked to the carboxyl-terminal transcriptional activation domain of Elk 1, c-Myc, or VP16. The GAL4-c-Myc MT construct contains alanine substitutions at threonine 59 and serine 62 and cannot be phosphorylated by the ERKs. Thus, the constructs GAL4-c-Myc MT and GAL4-VP16 cannot be transactivated by MAPK and served as negative controls. A reporter gene containing five GAL4 binding sites upstream of a minimal promoter linked to luciferase was used to assess activation of the GAL4 fusion proteins. Transfection studies followed by stimulation with gastrin or PMA showed that gastrin and PMA both stimulated Elk-1-dependent transactivation (Fig. 3A) . In addition, gastrin was able to stimulate c-Myc-dependent transactivation with GAL4-c-Myc WT, whereas no stimulation was noted for GAL4-c-Myc MT or GAL4-VP16 (Fig. 3B) . The observation that gastrin is able to stimulate Elk-1-and c-Myc-dependent transactivation is consistent with gastrin-dependent ERK activation in the AGS-B cell line.
Gastrin and PMA Stimulate ERK Tyrosine Phosphorylation and ERK Activity-The preceding experiments demonstrated that gastrin can stimulate known downstream targets of ERK-1/2, suggesting a role for the ERK signal transduction cascade in mediating the nuclear responses to CCK-B/gastrin receptor activation. Activation of the ERKs has been shown to be dependent on phosphorylation of both threonine and tyrosine residues (28) . To determine if gastrin treatment leads to in- creased phosphorylation of tyrosine residues of the ERKs, we immunoprecipitated ERK-1 and ERK-2 proteins from AGS-B cell lysates with and without gastrin stimulation. The results for ERK-1 are shown in Fig. 4A . Gastrin treatment led to substantial increases in the phosphotyrosine content of both p44 ERK-1 and p42 ERK-2 (not shown), consistent with activation of these kinases.
Stimulation of ERK-1/2 kinase activity was determined by MBP assays of AGS-B cell extracts after immunoprecipitation of the ERKs. In this assay, gastrin and PMA treatment of AGS-B cells resulted in a rapid stimulation of MAPK activity (Fig. 4B) . Scanning densitometry revealed that gastrin and PMA stimulated ERK kinase activity up to 10-fold (Fig. 4C) .
Gastrin-and PMA-stimulated HDC Promoter Activity Is Inhibited by Kinase-deficient ERK Mutants or by the ERK-specific
Phosphatase PAC-1-To determine whether ERK function was necessary for gastrin-and PMA-stimulated hHDC promoter activity, we used kinase-deficient ERK mutants that have been shown previously to block endogenous ERK function efficiently and thus behave like dominant negative constructs (16, 17) . These mutants can be phosphorylated on activating sites but possess less than 5% of wild type activity and interfere with endogenous ERK-1 and ERK-2 activity. Expression of the kinase-deficient ERK mutants did not interfere with basal promoter activity (Fig. 5, A and B) . However, transfection of either K712R ERK-1 or K52R ERK-2 alone strongly inhibited the stimulatory effect of gastrin or PMA on the hHDC promoter in a dose-dependent fashion (Fig. 5, A and B) . Transfection of both constructs at the higher dose (0.5 g) completely abolished the effect of gastrin and PMA on the hHDC promoter (Fig. 5, A and  B) .
As an alternative approach for down-regulating ERK function, we transfected an expression construct for the ERK-specific phosphatase PAC-1 into AGS-B cells. PAC-1 is a dual specific Thr/Tyr phosphatase with stringent specificity for the ERKs (19) . Constitutive expression of PAC-1 leads to inhibition of ERK activity normally stimulated by EGF and PMA and inhibition of ERK-regulated reporter gene expression (19) . Expression of the PAC-1 construct in COS-7 cells has been shown to reduce PMA-stimulated ERK tyrosine phosphorylation and kinase activity to background levels, whereas expression of the catalytically inactive PAC-1 mutant had no effect (19) .
Expression of wild type PAC-1 did not affect basal promoter activity but completely abolished the ability of gastrin to stimulate the transcriptional activity of the HDC promoter, whereas the phosphatase-deficient mutant of PAC-1 (PAC-1 MT) was not able to block promoter induction (Fig. 5C ).
Gastrin and PMA Stimulate c-Jun-dependent Transactivation-To investigate the relationship between CCK-B/gastrin receptor activation and c-Jun activation, we examined the effect of gastrin on the GAL4-c-Jun (WT and MT) expression vectors and the 5ϫGAL4-Luc reporter gene. Both gastrin and PMA stimulated transactivation by GAL4-c-Jun WT but had no effect on the mutant construct, GAL4-c-Jun MT(AA) (Fig. 6A ). There was no additive effect on GAL4-c-Jun WT when exposed to both gastrin and PMA.
Because phosphorylation and transcriptional activity of cJun have been reported to occur through both the ERK and JNK pathways, we next examined the effect of MEK-1 and SEK-1 overexpression on GAL4-c-Jun activity compared with the effect on GAL4-Elk-1 activity. MEK-1 is the known upstream activator of the ERKs, whereas SEK-1 is a homologue of MEK-1 but is an upstream activator of the JNK pathway. As expected, GAL4-Elk-1 was strongly induced by transfection of MEK-1 but was not induced by transfection of SEK-1 (Fig. 6B) . In contrast, GAL4-c-Jun WT was strongly activated by cotransfection of SEK-1 but also moderately activated by cotransfection of MEK-1 (Fig. 6B) Further, whereas SEK-1 strongly induced GAL4-c-Jun activity, no inhibition of SEK-1 stimulation was observed with the kinase-deficient ERK-1 construct (ERK-1KR) (Fig. 6C) . In contrast, gastrin induction of GAL4-c-Jun activity was completely inhibited by ERK-1KR (Fig. 6C) , indicating that gastrin stimulates c-Jun phosphorylation and cJun-dependent transactivation in AGS-B cells primarily through the ERK branch of the MAPK signaling pathway.
SEK-1 Stimulates HDC Promoter Activity but Is Not Necessary for
Gastrin-stimulated HDC Activation-To investigate more directly a possible role for the JNK pathway in gastrinstimulated transcription, we examined the effect of overexpression constructs for WT and MT SEK-1 on HDC promoter activity. The effects of gastrin stimulation and SEK-1 WT cotransfection on HDC promoter activity were studied in combination with specific inhibitors of the ERK (ERK-1KR) and JNK (DN SEK-1) pathways. Both gastrin (3-4-fold) and WT SEK-1 (7-fold) stimulated HDC promoter activity. However, the effect of SEK-1 was blocked completely by dominant negative SEK-1 but not inhibited by the kinase-deficient ERK-1 (Fig. 7A) . In contrast, the effect of gastrin was not inhibited by dominant negative SEK-1 but was blocked completely by the kinase-deficient ERK-1 (Fig. 7A) . Thus, although the HDC promoter can be stimulated by overexpression of SEK-1 and presumed activation of the JNK pathway, the lack of inhibition by the dominant negative SEK-1 suggests that the JNK pathway is not essential for gastrin induction of HDC gene expression. Furthermore, whereas UV light treatment of AGS-B cells led to increased JNK phosphorylation, neither gastrin nor PMA treatment of AGS-B cells stimulated JNK phosphorylation (Fig. 7B) .
Gastrin and PMA Stimulate Tyrosine Phosphorylation of Shc and Association with Grb2-Previous studies in other cell systems have suggested possible roles for tyrosine phosphorylation in CCK-B/gastrin receptor signaling. Therefore, we examined the effect of gastrin and PMA on tyrosine phosphorylation in our AGS-B gastric cancer cell line. Serum-starved AGS-B cells were treated with either gastrin or PMA or left untreated (control). Cell lysates were run on an SDS-polyacrylamide gel followed by Western blotting with an anti-phosphotyrosine antibody. Increased tyrosine phosphorylation of numerous cellular proteins was observed after treatment with both gastrin and PMA (Fig. 8, second and third lanes from left) . To examine the effect on the phosphorylation of Shc and its association with Grb2, Grb2 and Shc proteins were first immunoprecipitated with specific antibodies, and phosphorylation was analyzed using an anti-phosphotyrosine antibody. As shown in Fig. 8 , immunoprecipitation using the anti-Shc antibody demonstrated increased tyrosine phosphorylation of both the 52-and 46-kDa isoforms of Shc after both gastrin and PMA stimulation (seventh and ninth lanes). In addition, identical bands were observed after cell lysates were immunoprecipitated with antiGrb2 antibody, indicating an association between tyrosinephosphorylated Shc and Grb2 (Fig. 8, sixth and eighth lanes) .
Gastrin and PMA Stimulate the HDC Promoter through a Ras-independent but Raf-1-dependent Pathway-Although increased phosphorylation of Shc proteins in response to gastrin suggests the activation of the p21-Ras signaling pathway, the relationship of Ras to gastrin-stimulated HDC promoter activity is unknown. To address this question, we cotransfected AGS-B cells with expression constructs for dominant negative (N17 or N15) Ras proteins and measured the effect on gastrinstimulated HDC promoter activity. Expression of RasN17 or RasN15 did not affect the response of the human HDC promoter to gastrin (Fig. 9A) . As a control, we showed that the transfection of the same constructs (RasN17 or RasN15) completely inhibited the response of the AP-1-dependent 4ϫTRE-CAT construct to epidermal growth factor stimulation.
Similar experiments were carried out to examine the role of Raf-1 in HDC promoter activation by gastrin. Raf-1 kinase is the primary upstream activator of MEK-1 and can itself be activated by forming a complex with Ras or through direct serine phosphorylation by protein kinase C. Expression of the dominant negative Raf-1 mutant in AGS-B cells completely inhibited stimulation of the HDC promoter by either gastrin or PMA (Fig. 9B) .
Finally, to assess the effects of gastrin and PMA on Raf-1 activity in AGS-B cells, Raf kinase activity was measured using MEK protein as a substrate (Fig. 9C) . These studies clearly demonstrate that both gastrin and PMA were capable of stimulating Raf-1 kinase activity.
The GAS-RE Functions as an ERK-1-responsive Element-To investigate further the mechanism by which ERK activates the HDC promoter, we analyzed a number of deletions of the HDC promoter for activation by ERK-1 overexpression. These studies indicated that the ERK-responsive element was located within the basal (Ϫ59 to ϩ125) hHDC promoter (not shown). In previous reports, we mapped the HDC GAS-RE to a 23-base pair element located just downstream of the transcriptional start site (Fig. 10) . Ligation of the GAS-RE enhancer upstream of the gastrin-insensitive TK promoter in the TK-Luc construct resulted in a 4 -5-fold response to ERK-1 overexpression (using CMV-ERK-1), indicating that the GAS-RE was mediating the response to ERK expression. In addition, the GAS-RE construct also showed a 4-fold response in cotransfection studies with WT SEK-1 but not to the mutant (DN SEK-1) construct (Fig. 10) . DISCUSSION Our studies suggest that the ERK-dependent signaling pathways mediate the stimulatory effects of gastrin on the transcription of the HDC gene. Several different lines of evidence are consistent with this conclusion. Overexpression of wild type ERK-1 and ERK-2 induced HDC promoter activity dose-dependently, suggesting a regulatory function for these kinases on the activity of the HDC promoter. A second approach involved expression of a constitutively active form of MEK-1 which would be expected to activate endogenous ERKs in AGS-B cells. Previous studies have shown that the MEK-1 mutant ⌬-N3-S218E-S222D results in constitutive activity as well as loss of responsiveness to upstream activators (20) . Thus, although overexpression of WT MEK-1 resulted in a minimal increase in HDC promoter activity, the ⌬-N3-S218E-S222D mutant form of MEK-1 was able to increase by severalfold the expression of an HDC reporter gene but showed no response to gastrin or PMA. These data support the concept that activation of the endogenous ERKs is sufficient to stimulation transcription of the HDC gene and that gastrin and PMA regulate the HDC promoter through a MEK-1-dependent signaling route.
In addition, we found that gastrin and PMA were able to stimulate tyrosine phosphorylation of ERK-1 and ERK-2 and kinase activity in gastric cancer (AGS) cells. Previous studies have shown that ERK activity is elevated after stimulation of CCK-B/gastrin receptors in several different cell types (29 -31), but they did not address the role in activating important downstream targets. We found that activation of the CCK-B/gastrin receptor in AGS-B cells was sufficient to activate ERK-regulated transcription factors such as c-Myc and Elk-1, consistent with an important role for this pathway in the transmission of gastrin-dependent signals into the nucleus. Importantly, we found that expression of kinase-deficient ERKs or the ERKspecific phosphatase PAC-1 which interfere with the ERK cascade blocked completely gastrin-and PMA-induced activation of the HDC gene. Overall, these findings demonstrate that gastrin activates the ERK cascade and that this pathway represents the major signaling route for gastrin-dependent regulation of the HDC promoter.
Because we have shown recently that activation of c-jun and AP-1 leads to increased HDC transcription (13), we also investigated a role for JNK-dependent signaling. The JNKs (JNK-1 and JNK-2) are distant relatives of the MAPKs and were identified initially based on their ability to phosphorylate and activate c-Jun. The murine SEK-1 gene (and the human homologue, MKK4) are upstream kinases that activate JNKs by phosphorylation of the Thr-Pro-Tyr sequence (14) . JNKs are activated by agents that induce cellular stress, such as UV light and tumor necrosis factor ␣, although JNKs may also be activated by tyrosine kinase growth factors such as epidermal growth factor in a Ras-dependent manner. Recently, Dabrowski et al. (32) have shown that JNKs are activated rapidly in isolated rat pancreatic acini after CCK-A receptor activation.
Overall, our studies do not suggest an important role for the JNK pathway in the activation of HDC by gastrin. First, although our studies using the GAL4-c-Jun/GAL4-Luc system indicate that c-Jun phosphorylation and transactivation are increased by gastrin stimulation, we have shown that the activation is most likely secondary to ERK activation rather than to activation of JNK pathways. Second, although our data indicate that activation of JNK (via overexpression of SEK-1) can activate HDC promoter activity, this pathway is clearly distinct from the gastrin pathway. Gastrin stimulation of HDC promoter activity was blocked completely by the kinase-deficient ERK-1 mutant, whereas SEK-1 stimulation of HDC was not blocked by the kinase-deficient ERK-1. The lack of effect of the dominant negative SEK-1 mutant, which blocks JNK activation by extracellular stimuli without interfering with the ERK pathway, on gastrin stimulation of HDC promoter activity also suggests that the JNK pathway is probably not required for the gastrin-stimulated response. Finally, neither gastrin nor PMA appeared to be able to stimulate phosphorylation of JNK in AGS-B cells.
Recent studies indicate that G-protein-coupled receptors can activate the ERKs through several different mechanisms (33) . G i -coupled receptors, such as the thrombin (34), lysophosphatidic acid (35) , ␣ 2 -adrenergic (36), and m2 muscarinic (37) , are similar to tyrosine kinase receptors in that they activate the ERKs through a Ras-dependent pathway. Activation of G icoupled receptors leads to tyrosine phosphorylation of Shc and its association with Grb2, a protein that links growth factor receptors to the Ras guanine nucleotide exchange factors. Activation of the ERKs by G i -coupled receptors is mediated by the G-protein ␤␥ subunits and thus can be blocked not only by dominant negative RasN17 but also by coexpression of a ␤␥-binding COOH-terminal peptide derived from ␤ARK1 (␤ARK1ct) (38) . However, the signaling pathways coupling G qlinked receptors to ERK activation are less clear and may involve Ras-independent pathways. For example, stimulation of ERK activity by G q -coupled receptors such as m1 muscarinic and the ␣ 1 -adrenergic is insensitive to the G␤␥-sequestering ␤ARK1cf peptide and RasN17 (38, 39) . Instead, ERK activation by G q -coupled receptors occurs predominantly through a Rasinsensitive, protein kinase C-dependent pathway (40) . The GTP-bound ␣-subunit of the G q /11 protein activates phosphoinositide hydrolysis and protein kinase C, which then stimulate ERK activation via a poorly understood mechanism involving the activation of Raf-1 kinase (41, 42) .
Several studies have suggested that the Ras pathway can be activated through agonist stimulation of members of the CCK receptor family (30, 43) . However, these studies did not address the issue as to whether activation of Ras is important for receptor-dependent cellular functions such as the transcriptional regulation of cell-specific genes. Our results in AGS-B cells demonstrate that CCK-B/gastrin receptor activation leads to Shc tyrosine phosphorylation association with Grb2, suggesting possible activation of the Ras pathway. However, although these assays support the idea that Ras is most likely activated by gastrin, stimulation of HDC promoter activity was unaffected by the RasN17 or RasN15 dominant negative mutants. In contrast, gastrin-stimulated Raf-1 kinase activity and expression of the dominant negative Raf-1 protein blocked completely gastrin-stimulated activity of the HDC promoter. Thus, taken together, our results suggest that in gastric cells, the CCK-B/gastrin receptor is linked through a Ras-independent, Raf-dependent mechanism to ERK-related signaling pathways, which are essential for the regulation of HDC transcriptional activity by this G-protein-coupled receptor.
Finally, overexpression of ERK-1/2 appeared to activate the HDC promoter through the previously identified gastrin response element or GAS-RE, a 23-base pair element located downstream of the start site. The mechanism by which gastrin stimulation activates the GAS-RE remains unclear but presumably involves increased binding by a novel nuclear factor (the GAS-RE-binding protein) (12) . Further studies will be required to determine if the GAS-RE-binding protein indeed represents a novel downstream target for the ERK pathway.
